Live-attenuated Yersinia pestis vaccines

被引：2

作者：

Wang, Xiaoyi ^{[1
]}

Zhang, Xuecan ^{[1
]}

Zhou, Dongsheng ^{[1
]}

Yang, Ruifu ^{[1
]}

机构：

[1] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China

来源：

EXPERT REVIEW OF VACCINES | 2013年 / 12卷 / 06期

关键词：

live-attenuated vaccines; plague; Yersinia pestis; PNEUMONIC PLAGUE; BUBONIC PLAGUE; FUSION PROTEIN; PLASMINOGEN-ACTIVATOR; TRANSFERABLE PLASMID; PROTECTIVE IMMUNITY; PASTEURELLA-PESTIS; TRANS-TRANSLATION; RECEPTOR PROTEIN; SUBUNIT VACCINE;

D O I：

10.1586/ERV.13.42

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Plague caused by Yersinia pestis is one of the most dangerous infectious diseases. There is no ideal plague vaccine available for human use, but a number of licensed killed whole-cell and live-attenuated vaccines have been available in the past. Currently, there are a number of vaccines under development, including live-attenuated, DNA and subunit vaccines, among others. This review deals with the development of live-attenuated plague vaccines. Traditionally, live-attenuated plague vaccines have been developed by multiple passages of fully virulent Y. pestis, but they have not gained general acceptance due to safety concerns. Recent attempts to construct attenuated Y. pestis strains with specifically defined mutations have opened the door for developing new candidates for live-attenuated plague vaccines, with a proper balance between safety and protective efficacy.

引用

页码：677 / 686

页数：10

共 50 条

[41] Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines
Ebenig, Aileen
Lange, Mona, V
Muehlebach, Michael D.
NPJ VACCINES, 2022, 7 (01)
[42] Live-Attenuated Vaccines in Solid Organ Transplant: Is It Time for a Practice Change?
Piche-Renaud, Pierre-Philippe
Upton, Julia Elizabeth Mainwaring
PEDIATRIC TRANSPLANTATION, 2024, 28 (08)
[43] Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines
Wiggan, O'Neil
Livengood, Jill A.
Silengo, Shawn J.
Kinney, Richard M.
Osorio, Jorge E.
Huang, Claire Y. -H.
Stinchcomb, Dan T.
VACCINE, 2011, 29 (43) : 7456 - 7462
[44] Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines
Folorunso, Olufemi Samuel
Sebolai, Olihile M.
VACCINES, 2020, 8 (03) : 1 - 64
[45] RECONVERSION OF HISTOPLASMIN SKIN TEST - REACTION WITH LIVE-ATTENUATED VIRAL VACCINES
SMITH, J
HUGHES, WT
SOUTHERN MEDICAL JOURNAL, 1967, 60 (12) : 1351 - &
[46] Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens
Jang, Hyesun
Elaish, Mohamed
Mahesh, K. C.
Abundo, Michael C.
Ghorbani, Amir
Ngunjiri, John M.
Lee, Chang-Won
PLOS ONE, 2018, 13 (04):
[47] Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines
Martinez-Sobrido, Luis
de la Torre, Juan Carlos
EXPERT REVIEW OF VACCINES, 2016, 15 (09) : 1113 - 1121
[48] Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines
Schmid, D. Scott
Miao, Congrong
Leung, Jessica
Johnson, Michael
Weinberg, Adriana
Levin, Myron J.
JOURNAL OF VIROLOGY, 2021, 95 (12)
[49] Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines
Kim, Dae-Sun
Nam, Jae-Hwan
EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (02) : 179 - 190
[50] Herpes Simplex Vaccines: Prospects of Live-Attenuated HSV Vaccines to Combat Genital and Ocular Infections
Stanfield B.
Kousoulas K.G.
Current Clinical Microbiology Reports, 2015, 2 (3) : 125 - 136

← 1 2 3 4 5 →